All
Talk on cutaneous mucinoses revisits lichen myxedematosus
September 1st 2006London - Lichen myxedematosus (LM) is not a single disease, but represents two clinicopathologic subsets that are important to distinguish because they differ with respect to prognosis and treatment, said Franco Rongioletti, M.D., at the annual meeting of the European Association of Dermatology and Venereology.
Fungal Infections: Current therapies, solutions
September 1st 2006San Diego - A multitude of fungi live in our ecosystem, and we can hope for peaceful coexistence with them - staying free from infection - but this is not always the rule. Sometimes when the immune system takes a turn for the worse fungi seize the opportunity to multiply and clinical presentation is the result.
Total body photography not standard of care
September 1st 2006Eckley M. Keach's article in the June 2006 issue of Dermatology Times ("Successful malpractice defense lies in body of evidence") provides tips for dermatologists to reduce the risk of malpractice liability from treating high-risk melanoma patients.
Managing rosacea: Practitioners discuss trends
September 1st 2006I recently moderated numerous advisory panels during which we spoke to 226 practicing specialists in the field of dermatology on the topic of rosacea management. The panels were conducted across the United States and included dermatologists, nurse practitioners and physician assistants. We met in small groups, mixing didactic presentations with open-ended discussions. We discussed a wide array of topics, from the history of rosacea therapies in the United States to new frontiers for topical treatments.
Medical practice from both sides now
September 1st 2006My professional life has changed radically over the past several months. I have left academic medicine and have started a private practice. Living in the professional cocoon of the university, I had absolutely no idea of the complexities, pressures, anxieties and great joy associated with this enterprise. I never dreamed that I would be paying a practice management consultant, a phone installation consultant, an employee health insurance agent, a computer consultant, an office security consultant, a janitorial consultant and the credit card processing company sales associate to provide advice.
AAD hopes iPledge survey will prompt program changes
September 1st 2006Schaumburg, Ill. -- The American Academy of Dermatology (AAD) hopes results of its recent iPLEDGE survey will prompt changes in the federal isotretinoin registry, which doctors and patients say is cumbersome and frustrating and hampers the delivery of quality medical care.
Study reports effectiveness of diphencyprone in palmoplantar-wart treatment
August 4th 2006Parkville, Victoria, Australia -- Researchers here report that patient-applied ointment comprising 0.1 percent diphencyprone and 15 percent salicylic acid in white soft paraffin is effective in treating palmoplantar warts.
FDA approves sunscreen product containing previously banned ingredient
August 4th 2006Washington -- In a move considered by many to be long overdue, the Food and Drug Administration (FDA) has approved a sunscreen product that contains Mexoryl, an ingredient considered to be more effective than other filters in protecting the skin against the sun's potentially damaging UVA rays.
Improving treatments HELP rosacea sufferers
August 1st 2006National report - While rosacea remains incurable for the estimated 14 million people who suffer from the condition, treatment options are evolving to provide dermatologists with a more effective armamentarium in helping to control the condition.
Benefits of metronidazole gel for rosacea treatment
August 1st 2006National report - Results of a phase 3B study comparing once daily treatment with the new 1 percent metronidazole gel (MetroGel, Galderma) and twice daily application of 15 percent azelaic acid gel (Finacea, Intendis) demonstrate that the two products have statistically similar efficacy, safety and tolerability in the treatment of moderate papulopustular acne, says John E. Wolf, Jr., M.D., professor and chairman, department of dermatology, Baylor College of Medicine, Houston.
Oral, anti-inflammatory rosacea drug: Effective, safe, approved
August 1st 2006Las Vegas - Rosacea treatment has taken a giant step forward with the Food and Drug Administration's recent approval of Oracea - doxycycline controlled-release capsules made by CollaGenex Pharmaceuticals. Oracea is the first FDA-approved, orally administered, systemically delivered drug to treat rosacea. It was approved for the treatment of inflammatory papules and pustules of rosacea in adult patients, and is currently available to dermatologists.
CDC to investigate mysteries of Morgellons disease
August 1st 2006Atlanta - The federal government's Centers for Disease Control and Prevention has announced that it will begin investigating a mysterious disease for which no cause has been identified - and which most medical professionals, including dermatologists, believe isn't a disease at all, but a psychotic disorder.
Field therapy important complement for optimal treatment of AKs
August 1st 2006Baltimore - Treatment for persons with numerous actinic keratoses (AKs) in an area of severely sun-damaged skin should include field therapy that can clear both the clinically evident lesions and sub-clinical danger spots, according to Anthony A. Gaspari, M.D., speaking at the East Coast Dermatology Seminar, here.
Dissecting microenvironmental factors, genetic alterations
August 1st 2006Philadelphia - There are multiple steps and mechanisms necessary for carcinogenesis, including multiple genetic alterations that cause an initiation phase, as well as microenvironmental factors that contribute to a promotion phase and a progression phase of a skin cancer.
Physician extenders an asset; be aware of liability issues
August 1st 2006National report - When a patient suffers damages as a result of care administered by a physician extender and a malpractice suit arises, then the physician as well as the physician extender will likely be sued, says David J. Goldberg, M.D., J.D.
New barrier dressing reduces pain, costs in partial-thickness burns
August 1st 2006Las Vegas - A nonwoven hydrofiber dressing with silver (Aquacel Ag) requires fewer dressing changes and fewer procedural medications, says Daniel M. Caruso, M.D., speaking at the annual meeting of the American Burn Association, here.
Nonsurgical techniques for treating skin cancer
August 1st 2006Noninvasive skin cancer treatment can be an attractive option for patients, especially in this age of new techniques and pharmaceutical discovery. But with new and exciting advancements often come new and complex questions. Dermatology Times asked Ronald Moy, M.D., a Los Angeles Mohs surgeon and former professor at the University of California, Los Angeles, and Marc D. Brown, M.D., a Mohs surgeon and professor of dermatology and otolaryngology at the University of Rochester Medical School, Rochester, N.Y., to discuss noninvasive skin cancer treatments.
IPLEDGE offers benefits some may not have considered
August 1st 2006Scottsdale, Ariz. - For many dermatologists, the new iPLEDGE registry has brought hassles and headaches, but there are plenty of benefits to be considered that could ultimately make the initial ordeal worthwhile, said Hilary Baldwin, M.D., at a recent meeting of the Skin Disease Education Foundation.